Yahoo
NasdaqCM - Nasdaq Real Time Price USD

enGene Therapeutics Inc. (ENGN)

1.4500 -0.0800 (-5.23%)
At close: November 2 at 4:00:02 PM EST
Trade ENGN on Coinbase
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
10/31/2025
10/31/2024
10/31/2023
10/31/2022
Total Assets
221,468
311,173
86,959
23,909
Total Liabilities Net Minority Interest
53,758
38,561
14,473
47,405
Total Equity Gross Minority Interest
167,710
272,612
72,486
-23,496
Total Capitalization
183,034
295,085
81,702
7,349
Preferred Stock Equity
--
--
--
53,118
Common Stock Equity
167,710
272,612
72,486
-76,614
Capital Lease Obligations
8,469
1,850
0
0
Net Tangible Assets
167,710
272,612
72,486
-23,496
Working Capital
169,412
232,701
80,183
17,479
Invested Capital
191,036
295,784
82,264
-44,504
Tangible Book Value
167,710
272,612
72,486
-76,614
Total Debt
31,795
25,022
9,778
32,110
Net Debt
--
--
--
11,676
Share Issued
52,018.6580
50,976.6760
23,197.9760
23,197.9760
Ordinary Shares Number
52,018.6580
50,976.6760
23,197.9760
23,197.9760
10/31/2022 - 2/1/2022

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: